ALK and non-small cell lung carcinoma: Patients with non‐small cell lung cancer (NSCLC) harboring the echinoderm microtubule‐associated protein‐like 4 (EML4)–ALK fusion exhibit remarkable initial responses to ALK‐TKIs.